Compare Duolingo Inc (DUOL) vs GeneDx Holdings Corp (WGS) Price & Performance

Duolingo (DUOL) trades at $151.22, down 0.33% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with 2025 revenue reaching $1.04 billion and net income of $414.07 million, representing a 35.87% net margin. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $0.66 surpassing the $0.604 estimate. Technical analysis shows support at $150 and resistance at $152, with the stock trading near recent highs.

Duolingo presents a compelling growth story with strong profitability metrics and consistent earnings beats, though valuation multiples remain elevated. Key risks include insider selling activity and competitive pressures in the edtech space. Analyst consensus leans cautious with 54% hold ratings, but the company's AI-driven content creation and user growth strategy provides long-term upside potential if monetization improves.

GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.

The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.